Abstract
The objective of this GCP-compliant clinical field study was to evaluate the efficacy of the combination of moxidectin (minimum dose of 2.5 mg/kg body weight) and imidacloprid (minimum dose of 10.0 mg/kg body weight) spot-on (Advocate®) as a preventive and therapeutic treatment of natural infection by Dirofilaria repens in dogs in the Czech Republic.
There were two arms of the study, both negatively controlled. 34 animals were randomly allocated to two groups of the treatment arm; 90 negative animals were randomly allocated to the prevention arm groups. All enrolled dogs were observed physically and blood was sampled monthly for Dirofilaria repens microfilaria counts for 18 months by modified Knott test and PCR. 34 dogs were positive for microfilaria and enrolled in the treatment arm of this study (treated: 18, untreated: 16). The reduction of the log-transformed microfilaria counts was significantly higher in the treatment group on day 28 (p = 0.007), 56, 84 and 112 (p < 0.001). All animals treated were negative after a single treatment. In the untreated control group 93.75 % remained positive (p < 0.001). 87 dogs were negative for microfilaria prior to allocation to the “preventive” arm (treated: 49; untreated: 38; 3 excluded). One dog in the untreated control group became positive for Dirofliaria repens microfilaria, while none of the treated dogs became positive.
Advocate® was effective in the treatment of dogs infected with microfilaria of Dirofilaria repens. Due to the low rate of natural infections the preventive efficacy could not be proven, but no dog treated became positive.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Arther RG, Bowman DD, Slone RL, Travis LE (2005) Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofilaria immitis) in dogs. Parasitol Res. 2005, Oct; Res 97(Suppl 1):76 – 80.
Baneth G, Volansky Z, Anug Y, Favia G, Bain O, Goldstein RE, Harrus S (2002) Dirofilaria repens infection in a dog: diagnosis and treatment with melarsomine and doramectin. Vet Parasitol 105:173 – 178.
Bowman DD, Johnson RC, Ulrich ME et al. (1992) Effects of long-term administration of ivermectin and milbemycin oxime on circulating microfilariae and parasite antigenemia in dogs with patent heartworm infections. In: Proceedings of the Heartworm Symposium, Austin, TX, 1992, pp 151 – 158.
Dobešová R, Svobodova V (2009) Progressive spread of Dirofilaria infections in dogs along rivers in the Southeastern Czech Republic. Second European Dirofilaria Days, Salamanca, Spain, p 190.
Dobson RJ, Sangster NC, Besier RB, Woodgate RG (2009) Geometric means provide a biased efficacy result when conducting faecal egg count reduction test (FECRT). Vet Parasitol 161:162 – 167.
Duscher G, Feiler A, Wille-Plazzai W, Bakonyi T, Leschnik M, Miterpáková M, Kolodziejek J, Nowotny N, Joachim A (2009) Nachweis von Dirofilarien in österreichischen Hunden. Berl Münch Tierärztl Wochenschr 122:199 – 203.
EMEA/CVMP/816/00-Final: Guideline on statistical principles for veterinary clinical trials.
Fok É, Szabo Z, Farkas R (1998) The first autochthonous case of a dog infected with Dirofilaria repens in hungary. Kisal Latorvoslás 4:218 – 219.
Fok É, Jascó O, Szebeni Z, Györffy A, Südkösd l, Lukács Z, Schaper R (2010) Elimination of Dirofilaria (syn. Nochtiella) repens microfilariae in dogs with monthly treatments of moxidectin 2.5 %/imidacloprid 10 % (Advocate®, Bayer) spoton. Parasitol Res 106(5):1141 – 1149.
Genchi C, Poglayen G, Kramer L, Casiraghi M, Venco L, Brianti E (2002) Efficacy of selamectin in the prophylaxis of Dirofilaria repens infestations in dogs. Veterinaria 16(1):69 – 71.
Genchi M, Pengo G, Genchi C (2010) Efficacy of moxidectin microsphere sustained release formulation for the prevention of subcutaneous filarial (Dirofilaria repens) infection in dogs. Vet Parasitol 170:167 – 169.
Hermosilla C, Pantchev N, Dyachenko V, Gutmann M, Bauer C (2006) First autochthonus case of canine ocular Dirofilaria repens in Germany. Vet Rec 158:134 – 135.
Kershaw O, Dyachenko V, Gruber AD (2009) Kutane Dirofilariose beim Hund in Deutschland. Dtsch Tierärztl Wochenschr 116(7):273.
Marconcini A, Magi M, Hecht Contin B (1993) The value of ivermectin in the prophylaxis of Dirofilaria repens infestation in naturally infected dogs. Parassitologia 35:67 – 71.
McCall J (2005) The safety-net story about macrocyclic lactone heartworm preventives: a review, an update, and recommendations. Vet Parasitol 133:197 – 206.
Rishniw M, Barr SC, Simpson KW, Frongillo MF, Franz M, Domingues-Alpizar JL (2006) Discrimination between six species of canine microfilaria by a single polymerase chain reaction. Vet Parasitol 135:303 – 313.
Rossi L, Ferroglio E, Agostini A (2002) Use of moxidectin tablets in the control of canine subcutaneous dirofilariosis. Vet Rec 150:383.
Rossi L, Ferroglio E, Agostini A (2004) Use of an injectable sustained-release formulation of moxidectin to prevent canine subcutaneous dirofilariosis. Vet Rec 154:26 – 27.
Sassnau R, Dyachenko V, Pantchev N, Stöckel F, Dittmar K, Daugschies A (2009) Dirofilari repens Befall in einem Schlittenhunde- Rudel im Land Brandenburg. Tierärztl Prax Ausg K Kleintiere Heimtiere 37: 95 – 101.
Sasaki Y and Kitagawa, H (1993) Effects of milbemycin D on microfilarial number and reproduction of Dirofilaria immitis in dogs. J Vet Med Sci 55:763 – 769
Svobodova V, Svobodova Z, Beladicova V, Valentova D (2005) First cases of canine dirofilariosis in Slovakia, a case report. Vet Med Czech 50(11):510 – 512.
Svobodova Z, Svobodova V, Genchi C, Forejtek P (2006) The first report of authochthonous dirofilariosis in dogs in the Czech Republic. Helminthologica 43(4):242 – 245.
Svobodova Z, Svobodova V, Genchi C (2007) Dirofilaria repens infection in dogs in the Czech Republic. In: Genchi C, Rinaldi L, Cringoli G (eds), Mappe Parasitologie 8 – Dirofilaria immitis and Dirofilaria repens in dog and cat and human infection. Rolando Editore, Neapel, Italy, pp 199 – 200.
Traversa D, Aste G, Di Cesare A, Paoletti B, Di Tommaso M, Di Giulio M, Pampurini F, Tunesi C, Boar A (2011) Efficacy of a single administration of a spot-on solution containing imidacloprid 10 %/moxidectin 2.5 % in eliminating Dirofilaria repens microfilariae in naturally infected dogs. Vet Parasitol. doi:10.1016/j.vetpar.2011.02.018.
Trotz-Williams LA, Trees AJ (2003) Systematic review of the distribution of the major vector-borne parasitic infections in dogs and cats in Europe. Vet Rec 152:97 – 105.
Vasylyk NS (2004) Morhological and functional changes and adaptations and compensatory reactions in dog’s organism at dirofilariosis. Dissertation, National Agrarian University, Kiew, pp 1 – 22.
VICH guideline 7: Efficacy requirements for anthelmintics, overall requirements (Step 7, CVMP/VICH/832/99-corr) 1999.
VICH guideline 9: Good clinical practice (CVMP/VICH/595/98 – Final) 2000.
VICH guideline 19: Efficacy of anthelmintics: specific recommendations for canines (Step 7, CVMP/VICH/835/99 – Final) 1999.
WAAVP (World Association for the Advancement of Veterinary Parasitology): Guidelines for evaluating the efficacy of anthelmintics for dogs and cats (Accepted August 31, 1993).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://creativecommons.org/licenses/by-nc/2.0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
About this article
Cite this article
Hellmann, K., Heine, J., Braun, G. et al. Evaluation of the Therapeutic and Preventive Efficacy of 2.5 % Moxidectin / 10 % Imidacloprid (Advocate®, Bayer Animal Health) in Dogs Naturally Infected or at Risk of Natural Infection by Dirofilaria repens . Parasitol Res 109 (Suppl 1), 77–86 (2011). https://doi.org/10.1007/s00436-011-2404-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-011-2404-6